iShares Biotechnology ETF (NASDAQ:IBB) Shares Acquired by Avior Wealth Management LLC

Avior Wealth Management LLC lifted its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 128.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 7,386 shares of the financial services provider’s stock after acquiring an additional 4,157 shares during the quarter. Avior Wealth Management LLC’s holdings in iShares Biotechnology ETF were worth $977,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. PVG Asset Management Corp acquired a new position in shares of iShares Biotechnology ETF during the second quarter worth about $415,000. Huntington National Bank boosted its holdings in iShares Biotechnology ETF by 17.9% during the third quarter. Huntington National Bank now owns 1,054 shares of the financial services provider’s stock worth $153,000 after buying an additional 160 shares in the last quarter. National Bank of Canada FI boosted its holdings in iShares Biotechnology ETF by 5.9% during the third quarter. National Bank of Canada FI now owns 4,124 shares of the financial services provider’s stock worth $600,000 after buying an additional 229 shares in the last quarter. First Financial Bank Trust Division purchased a new stake in iShares Biotechnology ETF during the third quarter worth about $204,000. Finally, Thrive Wealth Management LLC purchased a new stake in iShares Biotechnology ETF during the third quarter worth about $445,000. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Price Performance

IBB stock opened at $137.30 on Friday. iShares Biotechnology ETF has a 52 week low of $123.60 and a 52 week high of $150.57. The company’s 50-day moving average price is $136.04 and its 200 day moving average price is $141.78.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were issued a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.